Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant

Cancer Causes and Control

Volumn 23, Issue 10, 2012, Pages 1593-1598

  Speaks, Crystal ^a   McGlynn, Katherine A ^b   Cook, Michael B ^b  

^a TULANE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Age period cohort; Calendar period deviations; Carcinoma in situ; Testicular cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CAUCASIAN; COHORT ANALYSIS; EXPOSURE; FEMALE; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTNATAL EXPOSURE; PRIORITY JOURNAL; SEMINOMA; TESTIS NONSEMINOMA CANCER; TREND STUDY; UNITED STATES;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; REGISTRIES; SEER PROGRAM; SEMINOMA; TESTICULAR NEOPLASMS; TIME FACTORS; UNITED STATES;

EID: 84867016747     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0036-5     Document Type: Article

References (40)

1. McGlynn KA, Cook MB (2009) Etiologic factors in testicular germ-cell tumors. Future Oncol 5(9):1389-1402. doi:10.2217/fon.09.116
2. Skakkebaek NE, Berthelsen JG, Muller J (1982) Carcinoma-in situ of the undescended testis. Urol Clin North Am 9(3):377-385
3. Sonne SB, Almstrup K, Dalgaard M, Juncker AS, Edsgard D, Ruban L, Harrison NJ, Schwager C, Abdollahi A, Huber PE, Brunak S, Gjerdrum LM, Moore HD, Andrews PW, Skakkebaek NE, Rajpert-De Meyts E, Leffers H (2009) Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res 69(12):5241-5250. doi:10.1158/0008-5472.CAN-08-4554
4. Oosterhuis JW, Kersemaekers AM, Jacobsen GK, Timmer A, Steyerberg EW, Molier M, Van Weeren PC, Stoop H, Looijenga LH (2003) Morphology of testicular parenchyma adjacent to germ cell tumours. An interim report. APMIS 111(1):32-40 (discussion 41-32)
5. von der Maase H, Rorth M, Walbom-Jorgensen S, Sorensen BL, Christophersen IS, Hald T, Jacobsen GK, Berthelsen JG, Skakkebaek NE (1986) Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 293(6559):1398-1401
6. Skakkebaek NE (1978) Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 2(3):157-170
7. Giwercman A, Skakkebaek NE (1993) Carcinoma in situ of the testis: biology, screening and management. Eur Urol 23(Suppl 2): 19-21
8. Aalen OO, Tretli S (1999) Analyzing incidence of testis cancer by means of a frailty model. Cancer Causes Control 10(4): 285-292
9. Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118(12):3099-3111
10. Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81(21):1668-1669
11. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63-70
12. Baade P, Carriere P, Fritschi L (2008) Trends in testicular germ cell cancer incidence in Australia. Cancer Causes Control 19(10):1043-1049. doi:10.1007/s10552-008-9168-z
13. Bray F, Richiardi L, Ekbom A, Forman D, Pukkala E, Cuninkova M, Moller H (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15(4):652-658
14. Liu S, Wen SW, Mao Y, Mery L, Rouleau J (1999) Birth cohort effects underlying the increasing testicular cancer incidence in Canada. Can J Public Health 90(3):176-180
15. Richiardi L, Bellocco R, Adami HO, Torrang A, Barlow L, Hakulinen T, Rahu M, Stengrevics A, Storm H, Tretli S, Kurti-naitis J, Tyczynski JE, Akre O (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13(12):2157-2166
16. Liu S, Semenciw R, Waters C, Wen SW, Mery LS, Mao Y (2000) Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects. Int J Epidemiol 29(5):826-831
17. Zheng T, Holford TR, Ma Z, Ward BA, Flannery J, Boyle P (1996) Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935-1992. Int J Cancer 65(6):723-729. doi:10.1002/(SICI)1097-0215(1996 0315)65:6\723:AID-IJC2[3.0.CO;2-0
18. Moller H (2001) Trends in incidence of testicular cancer and prostate cancer in Denmark. Hum Reprod 16(5):1007-1011
19. Sincic N, Kulis T, Znaor A, Bray F (2012) Time trends in tes-ticular cancer in Croatia 1983-2007: rapid increases in incidence, no declines in mortality. Cancer Epidemiol 36(1):11-15. doi: 10.1016/j.canep.2011.09.010
20. Rosenberg PS, Anderson WF (2010) Proportional hazards models and age-period-cohort analysis of cancer rates. Stat Med 29(11):1228-1238. doi:10.1002/sim.3865
21. Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, Rabkin CS (2010) Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 303(17):1723- 1728. doi:10.1001/jama.2010.496
22. Anderson WF, Jatoi I, Tse J, Rosenberg PS (2010) Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 28(2):232-239. doi:10.1200/JCO.2009.23.8162
23. Grimley PM, Matsuno RK, Rosenberg PS, Henson DE, Schwartz AM, Anderson WF (2009) Qualitative age interactions between low-grade and high-grade serous ovarian carcinomas. Cancer Epidemiol Biomarkers Prev 18(8):2256-2261. doi:10.1158/1055-9965.EPI-09-0240
24. Fritz AG (2000) International classification of diseases for oncology: ICD-O, 3rd edn. World Health Organization, Geneva
25. World Health Organization (2004) Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, Oxford University Press [distributor], Oxford
26. Waheeb R, Hofmann MC (2011) Human spermatogonial stem cells: a possible origin for spermatocytic seminoma. Int J Androl 34(4 Pt 2):e296-e305. doi:10.1111/j.1365-2605.2011.01199.x (discussion e305)
27. Holford TR (1983) The estimation of age, period and cohort effects for vital rates. Biometrics 39(2):311-324
28. Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates II: Age-period-cohort models. Stat Med 6(4): 469-481
29. Robertson C, Gandini S, Boyle P (1999) Age-period-cohort models: a comparative study of available methodologies. J Clin Epidemiol 52(6):569-583
30. Holford TR (1991) Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 12:425-457. doi:10.1146/annurev.pu.12.050191.002233
31. Rosenberg PS, Anderson WF (2011) Age-period-cohort models in cancer surveillance research: ready for prime time? Cancer Epidemiol Biomark Prev 20(7):1263-1268. doi:10.1158/1055-9965.epi-11-0421
32. Lerro CC, McGlynn KA, Cook MB (2010) A systematic review and meta-analysis of the relationship between body size and testicular cancer. Br J Cancer 103(9):1467-1474
33. McGlynn KA, Cook MB (2009) The epidemiology of testicular cancer. In: Cooney KA, Foulkes WD (eds) Male reproductive cancers: epidemiology, pathology and genetics, vol Cancer Genetics series. Springer Publications, New York
34. Daling JR, Doody DR, Sun X, Trabert BL, Weiss NS, Chen C, Biggs ML, Starr JR, Dey SK, Schwartz SM (2009) Association of marijuana use and the incidence of testicular germ cell tumors. Cancer 115(6):1215-1223. doi:10.1002/cncr.24159
35. Trabert B, Sigurdson AJ, Sweeney AM, Strom SS, McGlynn KA (2011) Marijuana use and testicular germ cell tumors. Cancer 117(4):848-853. doi:10.1002/cncr.25499
36. Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O (2007) Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 356(18):1835-1841
37. Wanderas EH, Tretli S, Fossa SD (1995) Trends in incidence of testicular cancer in Norway 1955-1992. Eur J Cancer 31A(12): 2044-2048
38. Moger TA, Aalen OO, Halvorsen TO, Storm HH, Tretli S (2004) Frailty modelling of testicular cancer incidence using Scandinavian data. Biostatistics 5(1):1-14. doi:10.1093/biostatistics/5.1.1
39. Zippin C, Lum D, Hankey BF (1995) Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76(11):2343-2350
40. Nathan H, Pawlik TM (2008) Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 15(2):415- 423. doi:10.1245/s10434- 007-9658-3